Summit Therapeutics, Inc. (SMMT)
17.53
+0.04
(+0.23%)
USD |
NASDAQ |
Jan 02, 15:32
Summit Therapeutics Shareholders Equity (Quarterly): 192.26M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Arrowhead Pharmaceuticals, Inc. | 466.05M |
| Insmed, Inc. | 945.57M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 261.73M |
| Total Liabilities (Quarterly) | 69.47M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 3.796 |
| Net Debt Paydown Yield | 0.13% |